All SARS-CoV-2 articles – Page 3
-
NewsNew study reveals how COVID-19 variants hijack human cells
A research team has successfully mapped what they call the “hijackome”, detailing how SARS-CoV-2 variants exploit specific cellular pathways.
-
NewsNew review highlights variant-specific differences in long COVID
Alpha and Delta variants have been linked to a higher prevalence of cardiopulmonary symptoms, such as breathlessness and chest pain, while Omicron infections show fewer severe cardiopulmonary effects but relatively higher incidences of fatigue and brain fog.
-
NewsFirst mouse strain that is susceptible to severe COVID-19 without genetic modification is IDed
Mice with a genetically pure background are susceptible to severe SARS-CoV-2 infection, providing an essential tool to develop vaccines and therapeutics for future coronavirus variants and potential pandemics
-
NewsNew antibody breakthrough offers hope against evolving SARS-CoV-2 variants
Researchers have discovered a groundbreaking monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 variants, including the elusive Omicron subvariants.
-
NewsTherapeutic tool inhibits the proliferation of the SARS-CoV-2 virus that causes COVID-19
A study led by the University of Barcelona and the Spanish National Research Council’s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. Source: University of Barcelona The experts Verònica Noé ...
-
NewsCovid-19 virus can damage the retina - even without severe respiratory disease
An experimental study in mice shows that SARS-CoV-2 infection can damage the retinas, with long-term implications for vision.
-
NewsStudy untangles how COVID-19 wreaks widespread damage in the body
A new study sheds light on the pathways that drive organ damage and death in severe COVID-19 and helps explain why survivors of the disease can experience long-term complications.
-
NewsResearchers develop lysosomal TRAP for clearance of viruses and variants
Researchers have developed a novel lysosomal strategy for clearing viruses and their variants. This lysosomal ‘TRAP’ (lysoTRAP) shows potential for inhibiting infection by viruses and variants in cell, mouse, hamster, and human lung organoid models.
-
NewsZoonotic transmission of Covid has led to infections in more than 30 mammalian species
Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in more than 30 mammalian species, according to a study published in Zoonoses journal.
-
NewsSimple COVID-19 vaccine can be stored at room temperature and administered as a nasal spray
Researchers have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray.
-
NewsSeemingly ‘broken’ genes in coronaviruses may be essential for viral survival
Some coronaviruses, including Covid-19 have extra ‘accessory’ genes in addition to the usual minimal viral set and researchers have found that some of these viral genes have stuck around even though they don’t produce a working protein.
-
NewsGlobal antibiotic consumption has increased by more than 21 percent since 2016
An analysis of antibiotic sales data from 67 countries from 2016-2023 shows a decrease in consumption in high-income countries countered by an increase in middle-income countries.
-
NewsA joint consensus report published on SARS-CoV-2 genomic surveillance for hospitals and public health laboratories
A joint consensus report that reviews and summarizes standard concepts and best practices for next-generation sequencing methods for SARS-CoV-2 genomic surveillance.
-
NewsNew therapeutic approach for severe COVID-19
A new clinical study shows that an inhibitor of Fas ligand, also called CD95 ligand, led to a faster recovery of COVID-19 patients and reduced mortality.
-
NewsStudies point to correlation between preeclampsia and COVID-19 in pregnant women
A review article by researchers discusses relationships between these two conditions, identifying biomarkers that can help clinicians make a differential diagnosis.
-
NewsScientists develop new SARS-CoV-2 variant detection method
Researchers have made a significant breakthrough in the fight against COVID-19 with the development of Intelli-OVI, a cutting-edge diagnostic tool capable of rapidly identifying emerging variants of the SARS-CoV-2 virus.
-
NewsSARS-CoV-2 ‘steals’ our proteins to protect itself from the immune system
Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly impairs viral clearance which may affect the course of ...
-
NewsAcquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
A new study presents two cases of immune thrombotic thrombocytopenic purpura occurring after the administration of the inactivated vaccine CoronaVac from Sinovac Biotech, highlighting the potential association between this type of vaccine and TTP.
-
NewsNanoparticles designed to trap and neutralise large amounts of SARS-CoV2
Researchers have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of materials.
-
NewsScientists assess efficacy of clinical drugs targeting SARS-CoV-2 main protease
A critical player in the virus’s life cycle is the main protease (Mpro), also known as NSP5 or 3CL protease, which plays a crucial role in the cleavage and maturation of SARS-CoV-2 proteins within the host cells.